This suggests that, while compensation for OA can partially alleviate endotoxemia symptoms, it cannot fully eliminate the worsening of endotoxemia symptoms due to the absence of Scd-1 (Figures 6A, B). The gene discussed is SCD; the disease is serum lipopolysaccharide activity.